Structure |
Chemical Name |
CAS |
MF |
|
Landiolol impurity S |
|
|
|
Mupirocin Calcium EP Impurity G |
|
C26H44CaO9 |
|
Hyoscine Butylbromide EP Impurity F |
|
|
|
Tocopherol EP Impurity D |
|
|
|
Org246653-1(RRT0.35) |
|
|
|
1H-Isoindole-1,3(2H)-dione, 2-[(2S)-2,3-dihydroxypropyl]- |
119835-88-0 |
C11H11NO4 |
|
Brexpiprazole Impurity 76 |
433303-94-7 |
C12H14N2S |
|
1,4-Naphthalenediol, 2-methyl-, 4-acetate |
110327-29-2 |
C13H12O3 |
|
Oseltamivir Impurity 105 |
|
|
|
Ezetimibe Related Impurity 37 |
204589-68-4 |
C24H19F2NO2 |
|
S, R-Isovalganciclovir Impurity |
1356932-18-7 |
C14H22N6O5 |
|
Sofosbuvir Impurity 8 |
944476-44-2 |
C24H22N2O8 |
|
1-((2'-cyanobiphenyl-4-yl)methyl)-4-methyl-2-propyl-1H-benzo[d]imidazole-6-carboxylic acid |
1098100-87-8 |
C26H23N3O2 |
|
Fimasartan Impurity |
|
|
|
2-(((5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methyl)(methyl)amino)succinic acid |
|
C21H20FN3O6S |
|
2-(DIETHYLAMINO)-N-(2,4-DIMETHYLPHENYL)ACETAMIDE |
17289-53-1 |
C14H22N2O |
|
(3RS)-3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one |
|
C16H20N2O |
|
Oxaliplatin impurity |
|
|
|
Febuxostat Impurity 78 |
|
|
|
Ibrutinib Impurity 21 |
1642571-08-1 |
C27H30N6O3 |
|
NiMesulide EP IMpurity |
38880-53-4 |
C7H8N2O5S |
|
Moxifloxacin Impurities |
|
|
|
Parecoxib Impurity K |
198471-69-1 |
C17H16N2O3S |
|
Linagliptin Impurity K |
1638744-06-5 |
C25H29BrN8O2 |
|
(R)-2-((6-(3-((3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile |
1917324-13-0 |
C31H28F2N8O4 |
|
L-Phenylalanine, N-[(5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl)carbonyl]-3-(methylsulfonyl)-, phenylmethyl ester, hydrochloride (1:1) |
1194550-65-6 |
C27H27Cl3N2O5S |
|
Etoricoxib Impurity 14 |
|
|
|
Riociguat Impurtiy 3 |
|
|
|
Trelagliptin Impurity 2 |
|
|
|
クロルヘキシジン二塩酸塩不純物B |
1308292-89-8 |
C16H26ClN9O |
|
Dapoxetine Impurity D |
|
|
|
Exemestane Impurity 1 |
159354-61-7 |
C20H24O3 |
|
Lidocaine Impurity |
35891-84-0 |
C11H16N2O.ClH |
|
Pramipexole Impurity J |
|
|
|
Solifenacin Related Compound 14 |
605696-10-4 |
C25H30N2O2 |
|
4-amino-1-((2R,3R,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one |
160552-54-5 |
C8H11N3O4S |
|
8-[(1R)-1-Hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethylethyl]amino]ethyl]-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one |
869478-13-7 |
C28H32N2O5 |
|
1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
743460-48-2 |
C21H27N3O2 |
|
Cefuroxime Sodium impurity D |
|
C16H16N4NaO8S |
|
Silodosin impurity A |
|
|
|
cefditoren △-3 isomer |
|
|
|
Ixazomib Impurity 1 |
1201903-02-7 |
C24H33BCl2N2O4 |
|
(3S)-9,10-difluoro-3-methyl-7-oxo-2,3,6,7-tetrahydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid |
1026952-91-9 |
C13H11F2NO4 |
|
((4-Methoxyphenoxy)methylene)dibenzene |
85686-16-4 |
C20H18O2 |
|
Tofacitinib Impurity L |
|
|
|
1-クロロ-3-(ジメトキシメチル)ベンゼン |
3395-80-0 |
C9H11ClO2 |
|
N-(3-ブロモ-4-オキソシクロヘキシル)アセトアミド |
687639-03-8 |
C8H12BrNO2 |
|
methyl (Z)-3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate |
|
C44H51N9O4 |
|
Alvimopan Impurity 5 |
|
|
|
Palbociclib-d8 |
1628752-83-9 |
C24H21D8N7O2 |
|
Ivabradine Impurity 15 |
1132667-04-9 |
C12H17NO2 |
|
Sofosbuvir Impurity27 |
|
|
|
Isavuconazole Impurity 12 |
|
|
|
Tacrolimus Impurity 3 |
161861-10-5 |
C45H71NO13 |
|
Lenvatinib Impurity 22 |
|
|
|
Moxifloxacin Impurity 47 |
|
|
|
Parecoxib sodium Impurity 35 |
|
|
|
Tofacitinib Impurity 20 |
1092578-44-3 |
C27H31N5O2S |
|
Tofacitinib Impurity 88 |
|
|
|
Vildagliptin Impurity ZA9 |
|
|
|
Nintedanib Impurity K |
|
|
|
13-Cis Vitamin A Palmitate |
26771-20-0 |
C36H60O2 |
|
Bortezomib Impurity 52 |
87304-47-0 |
C15H26BClO2 |
|
Moxifloxacin Impurity 20 HCl |
959347-97-8 |
C21H25N3O4 |
|
2-amino-3,5-dibromo-N-((1r,4r)-4-hydroxycyclohexyl)benzamide |
105735-86-2 |
C13H16Br2N2O2 |
|
Palonosetron Impurity TM1-RR |
1022895-91-5 |
C15H23ClN2 |
|
(1r,4r)-4-((2-amino-3-bromobenzyl)amino)cyclohexanol hydrochloride |
|
C13H20BrClN2O |
|
(1s,4s)-4-((2-amino-5-bromobenzyl)amino)cyclohexanol hydrochloride |
5579-35-1 |
C13H20BrClN2O |
|
Moxifloxacin oxide Impurity |
|
|
|
Edaravone Impurity 18 |
|
|
|
Linagliptin Impurity 47 |
|
|
|
(3R,5S,E)-7-(4-(4-fluorophenyl)-2-((2-hydroxy-N,2-dimethylpropyl)sulfonamido)-6-isopropylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid |
1715120-13-0 |
C25H34FN3O7S |
|
Cabozantinib impurity 28 |
|
|
|
Cabozantinib impurity 33 |
|
|
|
Ondansetron Impurity 2 |
|
|
|
Rivaroxaban Degradation Impurity C |
|
|
|
Irsogladine Impurity DQJ |
61382-84-1 |
C9H6Cl2N4O |
|
Pregabalin Impurity 7 |
70767-77-0 |
C8H13NO3 |
|
Pregabalin Impurity 13 |
1089315-68-3 |
C7H11NO3 |
|
Pralatrexate Impurity 7 |
|
|
|
Pitavastatin Impurity 39 |
|
|
|
Dapoxetine impurity 31 |
|
|
|
Lenvatinib Impurity 36 |
|
|
|
Sitafloxacin Impurity 19 |
|
|
|
Febuxostat Impurity 97 |
|
|
|
Dapoxetine impurity 32 |
|
|
|
Olprinone Impurity D |
|
|
|
Canagliflozin Impurity 48 |
|
|
|
Canagliflozin Impurity 54 |
|
|
|
Tofacitinib Impurity 105 |
|
|
|
Cabozantinib impurity Q |
|
|
|
Gadobutrol Impurity 1 |
216670-14-3 |
C22H42ClLiN4O6 |
|
Pemetrexed disodium EP Impurity B |
|
|
|
Crisaborole Impurity 7 |
|
|
|
Valnemulin EP Impurity A |
1624614-06-7 |
C31H52N2O6S |
|
Olprinone Impurity F |
|
|
|
Nicorandil Impurity E |
|
|
|
Prednicarbate Impurity G |
|
|
|
Ondansetron IMpurity 6 |
|
|
|
MeropeneM iMpurity 6 |
|
|